4,575 XNAS Volume
XNAS 19 Mar, 2025 11:30 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Georgiou Archelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 11,365 | 11,365 | - | - | Nonstatutory Stock Option (right to buy) | |
| McDonald Alan David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 11,365 | 11,365 | - | - | Nonstatutory Stock Option (right to buy) | |
| Michael McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 20,836 | 20,836 | - | - | Nonstatutory Stock Option (right to buy) | |
| Michael McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 1,967 | 1,967 | - | - | Non-qualified Stock Option (right to buy) | |
| Jon W. Salveson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 2,146 | 2,146 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gregory D. Waller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 2,146 | 2,146 | - | - | Nonstatutory Stock Option (right to buy) | |
| John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 2,146 | 2,146 | - | - | Nonstatutory Stock Option (right to buy) | |
| Warren S. Watson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 2,146 | 2,146 | - | - | Nonstatutory Stock Option (right to buy) | |
| Nestor Jaramillo | Director, President and CEO | 15 Mar 2023 | 4,098 | 4,098 (0%) | 0% | 4.8 | 19,629 | Common Stock | |
| Neil P. Ayotte | SVP, Secretary, GC & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 8,640 | 8,640 | - | - | Incentive Stock Option (right to buy) | |
| Nestor Jaramillo | Director, President and CEO | 03 Mar 2023 | 13,866 | 13,866 | - | - | Non-qualified Stock Option (right to buy) | ||
| Nestor Jaramillo | Director, President and CEO | 03 Mar 2023 | 8,954 | 8,954 | - | - | Incentive Stock Option (right to buy) | ||
| Lynn L. Blake | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 12,417 | 12,417 | - | - | Nonstatutory Stock Option (right to buy) | |
| Jon W. Salveson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,806 | 15,806 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gregory D. Waller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,806 | 15,806 | - | - | Nonstatutory Stock Option (right to buy) | |
| John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,806 | 15,806 | - | - | Nonstatutory Stock Option (right to buy) | |
| Warren S. Watson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,806 | 15,806 | - | - | Nonstatutory Stock Option (right to buy) | |
| Steve Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 15,806 | 15,806 | - | - | Nonstatutory Stock Option (right to buy) | |
| Neil P. Ayotte | SVP, Secretary, GC & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 26,352 | 26,352 | - | - | Incentive Stock Option (right to buy) | |
| Nestor Jaramillo | Director, President and CEO | 03 Mar 2022 | 101,190 | 101,190 | - | - | Incentive Stock Option (right to buy) | ||
| George Montague | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 40,054 | 40,054 | - | - | Incentive Stock Option (right to buy) | |
| John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2021 | 8,752 | 8,752 | - | - | Nonstatutory Stock Option (right to buy) | |
| George Montague | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 62,535 | 62,535 | - | - | Non-statutory Stock Option (right to buy) | |
| Neil P. Ayotte | SVP, Secretary, GC & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 41,690 | 41,690 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jon W. Salveson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 9,798 | 9,798 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gregory D. Waller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 9,798 | 9,798 | - | - | Nonstatutory Stock Option (right to buy) | |
| John L. Erb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 75,973 | 75,973 | - | - | Incentive Stock Option (right to buy) | |
| Warren S. Watson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 9,798 | 9,798 | - | - | Nonstatutory Stock Option (right to buy) | |
| Steve Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 9,798 | 9,798 | - | - | Nonstatutory Stock Option (right to buy) | |
| Nestor Jaramillo | Director, President and CEO | 19 May 2021 | 157,911 | 157,911 | - | - | Incentive Stock Option (right to buy) | ||
| John L. Erb | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 33,125 | 33,125 | - | - | Incentive Stock Option | |
| Claudia Drayton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 10,500 | 10,500 | - | - | Incentive Stock Option | |
| Nestor Jaramillo | Chief Executive Officer | 22 Jan 2021 | 12,750 | 12,750 | - | - | Incentive Stock Option | ||
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 18,849 | 18,849 | - | - | Nonstatutory Stock Option | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 18,849 | 18,849 | - | - | Nonstatutory Stock Option | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 18,849 | 18,849 | - | - | Nonstatutory Stock Option | |
| Steve Brandt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 18,849 | 18,849 | - | - | Nonstatutory Stock Option | |
| Maria Rosa Costanzo | Director | Other type of transaction at price $ 0.00 per share. | 03 Sep 2019 | 1,313 | 1,313 | - | - | Nonstatutory Stock Option | |
| Jon W. Salveson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 1,970 | 1,970 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gregory D. Waller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 1,970 | 1,970 | - | - | Nonstatutory Stock Option (right to buy) | |
| Warren S. Watson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 1,970 | 1,970 | - | - | Nonstatutory Stock Option (right to buy) | |
| Steve Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 1,970 | 1,970 | - | - | Nonstatutory Stock Option (right to buy) | |
| Matthew E. Likens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2019 | 1,970 | 1,970 | - | - | Nonstatutory Stock Option (right to buy) | |
| Nestor Jaramillo | Chief Commercial Officer | 23 May 2019 | 84,489 | 84,489 | - | - | Nonstatutory Stock Option | ||
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 12 Mar 2019 | 9,523 | 11,615 (0%) | 0% | 5.3 | 49,996 | Common Stock |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Mar 2019 | 9,523 | 9,523 | - | - | Series 2 Warrant to Purchase Common Stock (right to buy) | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Mar 2019 | 9,523 | 9,523 | - | - | Series 1 Warrant to Purchase Common Stock (right to buy) | |
| Gregory D. Waller | None | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 10 Aug 2018 | 72 | 2 (0%) | 0% | 1.0 | 74 | Common Stock |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 03 Jul 2018 | 23,584 | 29,355 (0%) | 0% | 2.1 | 49,998 | Common Stock |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Steve Brandt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Matthew E. Likens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2018 | 10,000 | 10,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2018 | 46,206 | 46,206 | - | - | Nonstatutory Stock Option (right to buy) | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2018 | 52,807 | 52,807 | - | - | Nonstatutory Stock Option (right to buy) | |
| John L. Erb | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2018 | 659,193 | 659,193 | - | - | Incentive Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2018 | 46,206 | 46,206 | - | - | Nonstatutory Stock Option (right to buy) | |
| Steve Brandt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2018 | 33,004 | 33,004 | - | - | Nonstatutory Stock Option (right to buy) | |
| Matthew E. Likens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2018 | 33,004 | 33,004 | - | - | Nonstatutory Stock Option (right to buy) | |
| Jim Breidenstein | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 181,068 | 181,068 | - | - | Incentive Stock Option (right to buy) | |
| Claudia Drayton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2018 | 197,746 | 197,746 | - | - | Incentive Stock Option (right to buy) | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2017 | 100 | 100 | - | - | Series F Convertible Preferred Stock | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2017 | 100 | 100 | - | - | Series 2 Warrant to Purchase Common Stock (right to buy) | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2017 | 100 | 100 | - | - | Series 1 Warrant to Purchase Common Stock (right to buy) | |
| Ki Yong Choi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 11 Oct 2017 | 30,141 | 1,793,109 (286%) | 4% | 0.5 | 14,468 | Common Stock |
| Ki Yong Choi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 11 Oct 2017 | 31,504 | 1,762,968 (281%) | 5% | 0.6 | 17,642 | Common Stock |
| Ki Yong Choi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 13 Sep 2017 | 78,211 | 1,731,464 (13%) | 0% | 0.6 | 50,055 | Common Stock |
| Ki Yong Choi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 08 Aug 2017 | 180,000 | 1,640,000 (13%) | 1% | 0.8 | 140,400 | Common Stock |
| Ki Yong Choi | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 08 Aug 2017 | 13,253 | 1,653,253 (13%) | 0% | 0.6 | 8,482 | Common Stock |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2017 | 8,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2017 | 8,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2017 | 8,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jim Breidenstein | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2017 | 339,145 | 339,145 | - | - | Non-qualified Stock Option (right to buy) | |
| Steve Brandt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2017 | 8,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Matthew E. Likens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2017 | 8,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Apr 2017 | 100,000 | 100,000 | - | - | Warrant to Purchase Common Stock (right to buy) | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Apr 2017 | 100,000 | 115,468 (3%) | 3% | 0 | Common Stock | |
| Steve Brandt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 1,437 | 1,437 (0%) | 0% | 0 | Common Stock | |
| Steve Brandt | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 903 | 903 | - | - | Non-qualified Stock Option (right to buy) | |
| Matthew E. Likens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 903 | 903 | - | - | Non-qualified Stock Option (right to buy) | |
| Matthew E. Likens | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2017 | 1,437 | 1,437 (0%) | 0% | 0 | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 15 Jan 2017 | 54 | 762 (0%) | 0% | 8.2 | 442 | Common Stock |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.20 per share. | 15 Jan 2017 | 41 | 909 (0%) | 0% | 8.2 | 336 | Common Stock |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Dec 2016 | 1,629 | 24,481 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Dec 2016 | 1,256 | 28,500 | - | - | Common Stock | |
| John L. Erb | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Nov 2016 | 80,000 | 464,128 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Nov 2016 | 1,629 | 26,110 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Nov 2016 | 1,256 | 29,756 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Oct 2016 | 1,629 | 27,739 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Oct 2016 | 1,256 | 31,012 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Sep 2016 | 1,629 | 29,368 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Sep 2016 | 1,256 | 32,268 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Aug 2016 | 1,629 | 30,997 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Aug 2016 | 1,256 | 33,524 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Jul 2016 | 1,629 | 32,626 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Jul 2016 | 1,256 | 34,780 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Jun 2016 | 1,629 | 34,255 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Jun 2016 | 1,256 | 36,036 | - | - | Common Stock | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 22,632 | 22,632 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 32,864 | 56,876 | - | - | Common Stock | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 22,632 | 22,632 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 32,864 | 46,039 | - | - | Common Stock | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 22,632 | 22,632 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 32,864 | 42,492 | - | - | Common Stock | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 22,632 | 22,632 | - | - | Non-Qualified Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2016 | 32,864 | 42,492 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 May 2016 | 1,629 | 35,884 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 May 2016 | 1,256 | 37,292 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Apr 2016 | 1,629 | 37,513 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Apr 2016 | 1,256 | 38,548 | - | - | Common Stock | |
| John L. Erb | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2016 | 534,000 | 534,000 | - | - | Incentive Stock Option (right to buy) | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Mar 2016 | 2,500 | 384,128 | - | - | Common Stock | |
| John L. Erb | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2016 | 356,000 | 381,628 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Mar 2016 | 1,629 | 39,142 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Mar 2016 | 1,256 | 39,804 | - | - | Common Stock | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Mar 2016 | 8,000 | 25,628 | - | - | Common Stock | |
| John L. Erb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Mar 2016 | 8,000 | 17,628 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Feb 2016 | 1,629 | 40,771 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Feb 2016 | 1,256 | 41,060 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 38,400 | 42,400 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 57,600 | 57,600 | - | - | Incentive Stock Option (right to buy) | |
| Molly Wade | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 29,600 | 42,316 | - | - | Common Stock | |
| Molly Wade | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2016 | 44,400 | 44,400 | - | - | Incentive Stock Option (right to buy) | |
| Eric Lovett | VP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2016 | 104,000 | 104,000 | - | - | Non-qualified Stock Option (right to buy) | |
| Claudia Drayton | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Nov 2015 | 1 | 760 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 23 Nov 2015 | 20 | 740 | - | - | Common Stock | |
| Brian Brown | SVP, Technology & Operations | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Aug 2015 | 4,000 | 20,000 | - | - | Common Stock | |
| Paul R. Buckman | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2015 | 10,000 | 24,012 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2015 | 4,000 | 29,500 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2015 | 500 | 500 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2015 | 3,500 | 4,000 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Aug 2015 | 5,226 | 119,587 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Aug 2015 | 557 | 25,500 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Aug 2015 | 607 | 12,716 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jul 2015 | 5,226 | 124,813 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jul 2015 | 557 | 26,057 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jul 2015 | 607 | 13,323 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2015 | 5,226 | 130,039 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2015 | 557 | 26,614 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2015 | 279 | 3,810 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2015 | 607 | 13,930 | - | - | Common Stock | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 3,692 | 3,692 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 5,439 | 14,012 | - | - | Common Stock | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 5,439 | 13,175 | - | - | Common Stock | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 3,692 | 3,692 | - | - | Non-Qualified Stock Option (right to buy) | |
| John L. Erb | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 3,692 | 3,692 | - | - | Non-Qualified Stock Option (right to buy) | |
| John L. Erb | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 5,439 | 9,628 | - | - | Common Stock | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 3,692 | 3,692 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 5,439 | 9,628 | - | - | Common Stock | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 3,692 | 3,692 | - | - | Non-Qualified Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2015 | 5,439 | 9,628 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2015 | 5,226 | 135,265 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2015 | 557 | 27,171 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2015 | 279 | 4,089 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2015 | 607 | 14,537 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Apr 2015 | 5,226 | 140,491 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Apr 2015 | 557 | 27,728 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Apr 2015 | 279 | 4,368 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Apr 2015 | 607 | 15,144 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2015 | 5,226 | 145,717 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2015 | 557 | 28,285 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2015 | 279 | 4,647 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2015 | 607 | 15,751 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2015 | 5,226 | 150,943 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2015 | 557 | 28,842 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2015 | 279 | 4,926 | - | - | Common Stock | |
| Molly Wade | Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2015 | 607 | 16,358 | - | - | Common Stock | |
| Claudia Drayton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2015 | 110,000 | 110,000 | - | - | Non-qualified Stock Option | |
| Claudia Drayton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2015 | 110,000 | 110,000 | - | - | Non-qualified Stock Option | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2015 | 953 | 37,223 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2015 | 680 | 33,309 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2015 | 5,226 | 156,170 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2015 | 557 | 29,399 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jan 2015 | 279 | 5,205 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2014 | 953 | 38,176 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2014 | 680 | 33,989 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2014 | 5,226 | 161,396 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2014 | 557 | 29,956 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2014 | 279 | 5,484 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Nov 2014 | 953 | 39,129 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Nov 2014 | 680 | 34,669 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Nov 2014 | 5,226 | 166,622 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Nov 2014 | 557 | 30,513 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Nov 2014 | 279 | 5,763 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Oct 2014 | 2,506 | 171,848 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2014 | 24,716 | 41,988 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Oct 2014 | 1,906 | 40,082 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Oct 2014 | 680 | 35,349 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Oct 2014 | 557 | 31,070 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Oct 2014 | 279 | 6,042 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Sep 2014 | 2,506 | 179,580 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Sep 2014 | 5,226 | 174,354 | - | - | Common Stock | |
| Brian Brown | SVP, Technology & Operations | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 5,000 | 10,000 | - | - | Common Stock | |
| Brian Brown | SVP, Technology & Operations | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 4,300 | 4,300 | - | - | Common Stock | |
| Brian Brown | SVP, Technology & Operations | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 6,000 | 16,000 | - | - | Common Stock | |
| Brian Brown | SVP, Technology & Operations | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 Sep 2014 | 700 | 5,000 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Sep 2014 | 458 | 17,272 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Sep 2014 | 329 | 36,029 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Sep 2014 | 200 | 31,627 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2014 | 680 | 36,358 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2014 | 557 | 31,827 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2014 | 279 | 6,321 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Aug 2014 | 2,506 | 187,312 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Aug 2014 | 5,226 | 182,086 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Aug 2014 | 5,000 | 11,384 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Aug 2014 | 5,000 | 16,384 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Aug 2014 | 458 | 17,730 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Aug 2014 | 329 | 37,038 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Aug 2014 | 200 | 32,384 | - | - | Common Stock | |
| William Peters | CTO and Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 24,716 | 37,367 | - | - | Common Stock | |
| William Peters | CTO and Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 37,073 | 37,073 | - | - | Incentive Stock Options (right to buy) | |
| David Rosa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 184,889 | 184,889 | - | - | Incentive Stock Options (right to buy) | |
| David Rosa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 123,259 | 189,818 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 29,700 | 29,700 | - | - | Incentive Stock Options (right to buy) | |
| Debra Kridner | Exec VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 19,800 | 32,584 | - | - | Common Stock | |
| Kimberly Oleson | SVP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 8,000 | 8,000 | - | - | Incentive Stock Options (right to buy) | |
| Kimberly Oleson | SVP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2014 | 6,600 | 6,600 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jul 2014 | 2,506 | 66,559 | - | - | Common Stock | |
| Brian Brown | SVP, Technology & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2014 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jul 2014 | 458 | 18,188 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jul 2014 | 329 | 12,651 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jul 2014 | 200 | 12,784 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jun 2014 | 2,506 | 69,065 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jun 2014 | 458 | 18,646 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jun 2014 | 329 | 12,980 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jun 2014 | 200 | 12,984 | - | - | Common Stock | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 2,766 | 2,766 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 4,189 | 8,573 | - | - | Common Stock | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 2,766 | 2,766 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 4,189 | 7,736 | - | - | Common Stock | |
| John L. Erb | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 4,189 | 4,189 | - | - | Common Stock | |
| John L. Erb | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 2,766 | 2,766 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 4,189 | 4,189 | - | - | Common Stock | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 2,766 | 2,766 | - | - | Non-Qualified Stock Option (right to buy) | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 May 2014 | 2,506 | 71,571 | - | - | Common Stock | |
| Geoffrey E Brooke | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 4,189 | 7,855 | - | - | Common Stock | |
| Geoffrey E Brooke | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 2,766 | 2,766 | - | - | Non-Qualified Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 4,189 | 4,189 | - | - | Common Stock | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 2,766 | 2,766 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kimberly Oleson | SVP, Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2014 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 May 2014 | 458 | 19,104 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 May 2014 | 329 | 13,309 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 May 2014 | 283 | 10,426 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 May 2014 | 200 | 13,184 | - | - | Common Stock | |
| James C Yearick | VP of Marketing and Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 May 2014 | 319 | 10,153 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Apr 2014 | 2,506 | 74,077 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Apr 2014 | 458 | 19,562 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Apr 2014 | 329 | 13,638 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Apr 2014 | 283 | 10,709 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Apr 2014 | 200 | 13,384 | - | - | Common Stock | |
| James C Yearick | VP of Marketing and Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Apr 2014 | 319 | 10,472 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Mar 2014 | 2,506 | 76,583 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Mar 2014 | 2,000 | 20,020 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Mar 2014 | 1,400 | 10,992 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Mar 2014 | 1,000 | 13,584 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Mar 2014 | 12,049 | 21,384 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 13 Mar 2014 | 7,951 | 13,967 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2014 | 458 | 18,020 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2014 | 329 | 21,918 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2014 | 283 | 9,592 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2014 | 200 | 12,584 | - | - | Common Stock | |
| James C Yearick | VP of Marketing and Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Mar 2014 | 319 | 10,791 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Feb 2014 | 2,506 | 79,089 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2014 | 458 | 18,478 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2014 | 329 | 22,247 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2014 | 283 | 9,875 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2014 | 200 | 12,784 | - | - | Common Stock | |
| James C Yearick | VP of Marketing and Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2014 | 319 | 11,110 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Jan 2014 | 2,506 | 81,595 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jan 2014 | 458 | 24,404 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jan 2014 | 329 | 26,576 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jan 2014 | 283 | 13,558 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jan 2014 | 200 | 15,378 | - | - | Common Stock | |
| James C Yearick | VP of Marketing and Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jan 2014 | 319 | 15,224 | - | - | Common Stock | |
| Paul R. Buckman | None | 31 Dec 2013 | 1,000 | 4,384 | - | - | Common Stock | ||
| Jeffrey S. Mathiesen | Chief Financial Officer | 31 Dec 2013 | 5,468 | 19,394 | - | - | Common Stock | ||
| William Peters | CTO & Medical Director | 31 Dec 2013 | 4,000 | 22,905 | - | - | Common Stock | ||
| David Rosa | Director, Chief Executive Officer | 31 Dec 2013 | 2,506 | 86,607 | - | - | Common Stock | ||
| David Rosa | Director, Chief Executive Officer | 31 Dec 2013 | 2,506 | 84,101 | - | - | Common Stock | ||
| Kevin Bassett | Senior VP, Tech & Operations | 31 Dec 2013 | 3,400 | 10,441 | - | - | Common Stock | ||
| Debra Kridner | Exec VP, Regulatory Affairs | 31 Dec 2013 | 2,395 | 13,184 | - | - | Common Stock | ||
| Jim Yearick | VP of Marketing and Sales | 31 Dec 2013 | 3,795 | 11,748 | - | - | Common Stock | ||
| David Rosa | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 29 Oct 2013 | 30,079 | 89,113 | - | - | Common Stock | |
| David Rosa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2013 | 118,192 | 119,192 | - | - | Common Stock | |
| Patrick Verta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2013 | 148,000 | 148,000 | - | - | Non-Statutory Stock Option (right to buy) | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 11,868 | 11,868 | - | - | Common Stock | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 11,868 | 23,736 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 11,951 | 27,892 | - | - | Common Stock | |
| William Peters | CTO & Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 11,951 | 15,941 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 7,345 | 7,345 | - | - | Common Stock | |
| Kevin Bassett | Senior VP, Tech & Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 7,345 | 14,690 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 7,095 | 7,095 | - | - | Common Stock | |
| Debra Kridner | Exec VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 7,095 | 14,190 | - | - | Common Stock | |
| Jim Yearick | VP of Marketing and Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 8,250 | 16,500 | - | - | Common Stock | |
| Jim Yearick | VP of Marketing and Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2013 | 8,250 | 8,250 | - | - | Common Stock | |
| Paul R. Buckman | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 3,384 | 3,384 | - | - | Common Stock | |
| Paul R. Buckman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2013 | 2,332 | 2,332 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gregory D. Waller | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 3,547 | 3,547 | - | - | Common Stock | |
| Gregory D. Waller | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2013 | 2,445 | 2,445 | - | - | Non-qualified Stock Option (right to buy) | |
| Jim Yearick | VP of Marketing and Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2013 | 35,000 | 35,000 | - | - | Incentive Stock Option (right to buy) | |
| Geoffrey Brooke | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2013 | 2,527 | 2,527 | - | - | Non-Qualified Stock Option (right to buy) | |
| Geoffrey Brooke | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2013 | 3,666 | 3,666 | - | - | Common Stock | |
| John L. Erb | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 54,000 | 54,000 | - | - | Stock Option (right to buy) | |
| Jon W. Salveson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 25,500 | 25,500 | - | - | Stock Option (right to buy) | |
| Warren S. Watson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2013 | 25,500 | 25,500 | - | - | Stock Option (right to buy) | |
| David Rosa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2013 | 347,000 | 347,000 | - | - | Stock Option (right to buy) | |
| William Peters | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2013 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| William Peters | Director, Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2012 | 3,990 | 3,990 | - | - | Common Stock | |
| William Peters | Director, Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2012 | 3,990 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jeffrey S. Mathiesen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2012 | 67,000 | 67,000 | - | - | Employee Stock Option - Right to Buy | |
| Kevin Bassett | VP Research, Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2012 | 42,000 | 42,000 | - | - | Employee Stock Option - Right to Buy | |
| Debra Kridner | VP Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2012 | 45,000 | 45,000 | - | - | Employee Stock Option - Right to Buy | |
| Jim Yearick | VP of Marketing and Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2012 | 15,000 | 15,000 | - | - | Employee Stock Option - Right to Buy | |
| Nicholas Callinan | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Sep 2012 | 2,500 | 32,147 | - | - | Common Stock | |
| Donal O'Dwyer | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2012 | 2,300 | 41,091 | - | - | Common Stock | |
| Donal O'Dwyer | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2012 | 11,375 | 52,466 | - | - | Common Stock |